COVID-19 Antigen Rapid Test self test

This kit is based on the principle of highly specific antibody-antigen reaction and colloidal gold labeling immunochromatographic analysis technology. The reagent contains COVID-19 monoclonal antibody prefixed in the test area (T) on the membrane and the COVID-19 monoclonal antibody coated on the label pad-colloidal gold mixture. The sample is dripped into the sample well and reacts with the COVID-19 monoclonal antibody which is bound to the pre-coated colloidal gold particles when testing. Then the mixture is chromatographed upwards with capillary effects. If it is positive, the antibody labeled by colloidal gold particles will first bind to the COVID-19 virus in the sample during chromatography. Then the conjugates are bound by the COVID-19 monoclonal antibody fixed on the membrane, and a red line appears in the test area (T). If it is negative, there's no red line in the test area (T). Whether the sample contains COVID-19 antigen or not, a red line will appear in the quality control area (C).

Biovantion Inc is independent from international department of Bioneovan Co., Ltd., which established in 2 0 0 5, is an in vitro diagnostic reagents manufacturer engaged in the research, development, production, and focus on clinical testing for infectious diseases, such as Hepatitis virus, Noro virus, Parvo virus test kits, our products include rapid test cassette and Elisa kits.

All our products have been registered in National Medical Products Administration of China, in year 2020 we get Certificate of ISO 13485:2016 – QUALITY MANAGEMENT SYSTEMS FOR MEDICAL DEVICES from SGS. More importantly, we have awarded the registration certificate from National Medical Products Administration for Diagnostic Kit for IgM Antibody to COVID-19 and IgG antibody to COVID-19 during the outbreak in China, and also we developed COVID-19 Antigen test ; Neutralizing Antibody Test, these products selling well all overthe world